1,476.72
-9.83 (-0.66%)
| Previous Close | 1,486.55 |
| Open | 1,486.00 |
| Volume | 57,245 |
| Avg. Volume (3M) | 146,088 |
| Market Cap | 30,419,013,632 |
| Price / Earnings (TTM) | 36.93 |
| Price / Earnings (Forward) | 31.75 |
| Price / Sales | 7.68 |
| 52 Weeks Range | |
| Earnings Date | 5 Feb 2026 |
| Profit Margin | 22.17% |
| Operating Margin (TTM) | 25.19% |
| Diluted EPS (TTM) | 40.10 |
| Quarterly Revenue Growth (YOY) | -4.60% |
| Quarterly Earnings Growth (YOY) | -7.80% |
| Current Ratio (MRQ) | 1.01 |
| Operating Cash Flow (TTM) | 972.81 M |
| Levered Free Cash Flow (TTM) | 743.66 M |
| Return on Assets (TTM) | 21.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Mixed |
| Diagnostics & Research (Global) | Bullish | Mixed | |
| Stock | Mettler-Toledo International, I | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | -1.5 |
| Insider Activity | -2.5 |
| Price Volatility | -3.0 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | 2.0 |
| Average | -1.70 |
|
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 101.90% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 1,700.00 (Citigroup, 15.12%) | Buy |
| Median | 1,475.00 (-0.12%) | |
| Low | 1,285.00 (JP Morgan, -12.98%) | Hold |
| Average | 1,490.63 (0.94%) | |
| Total | 4 Buy, 4 Hold | |
| Avg. Price @ Call | 1,381.52 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 1,550.00 (4.96%) | Hold | 1,447.16 |
| Barclays | 10 Nov 2025 | 1,600.00 (8.35%) | Buy | 1,432.57 |
| 02 Oct 2025 | 1,350.00 (-8.58%) | Buy | 1,300.54 | |
| Citigroup | 10 Nov 2025 | 1,700.00 (15.12%) | Buy | 1,432.57 |
| Stifel | 10 Nov 2025 | 1,600.00 (8.35%) | Buy | 1,432.57 |
| Wells Fargo | 10 Nov 2025 | 1,400.00 (-5.20%) | Hold | 1,432.57 |
| JP Morgan | 09 Oct 2025 | 1,285.00 (-12.98%) | Hold | 1,307.57 |
| Evercore ISI Group | 07 Oct 2025 | 1,400.00 (-5.20%) | Buy | 1,309.12 |
| B of A Securities | 22 Sep 2025 | 1,390.00 (-5.87%) | Hold | 1,258.05 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DE LA GUERRONIERE MARC | - | 1,506.02 | -6,055 | -9,118,951 |
| VADALA SHAWN | - | 1,488.08 | -2,025 | -3,012,914 |
| Aggregate Net Quantity | -8,080 | |||
| Aggregate Net Value ($) | -12,131,865 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 1,494.06 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| VADALA SHAWN | Officer | 25 Nov 2025 | Sell (-) | 1,000 | 1,506.02 | 1,506,020 |
| VADALA SHAWN | Officer | 25 Nov 2025 | Option execute | 1,000 | - | - |
| DE LA GUERRONIERE MARC | Officer | 25 Nov 2025 | Sell (-) | 6,055 | 1,506.02 | 9,118,951 |
| DE LA GUERRONIERE MARC | Officer | 25 Nov 2025 | Option execute | 6,055 | - | - |
| VADALA SHAWN | Officer | 24 Nov 2025 | Sell (-) | 1,025 | 1,470.14 | 1,506,894 |
| VADALA SHAWN | Officer | 24 Nov 2025 | Option execute | 1,025 | - | - |
| Date | Type | Details |
|---|---|---|
| 18 Nov 2025 | Announcement | Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences |
| 06 Nov 2025 | Announcement | Mettler-Toledo International Inc. Reports Third Quarter 2025 Results |
| 07 Oct 2025 | Announcement | Mettler-Toledo International Inc. to Host Third Quarter 2025 Earnings Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |